Form 4: Elevance Health Director Buys $869K in Stock

Elevance Health Director Steven H. Collis acquired 3,000 shares of common stock for approximately $869,520, signaling confidence in the company's future.

Summary

• Steven H. Collis, a Director of Elevance Health, Inc. (ELV), purchased 3,000 shares of common stock.
• The transaction occurred on March 5, 2026, at a price of $289.84 per share.
• The total value of the acquisition was $869,520.
• Following this transaction, Mr. Collis directly owns 3,639 shares of Elevance Health common stock.
• The purchase was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as a director's substantial personal investment indicates confidence in the company's trajectory and potential for shareholder value creation.

Positives

• A Director's purchase of 3,000 shares for $869,520 indicates strong insider confidence in Elevance Health's future prospects and valuation.
• The increase in direct beneficial ownership to 3,639 shares aligns the director's interests more closely with those of shareholders.

Negatives

• No specific negative points are present in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider buying, especially from a director, can be a positive signal in the healthcare industry, suggesting that management believes the company is undervalued or expects positive developments, potentially related to new policies, market expansion, or operational efficiencies. This move by a director of a major health insurer like Elevance Health could be interpreted as a vote of confidence amidst evolving healthcare landscapes.

Related Party Transactions

• The purchase of 3,000 shares of common stock by Director Steven H. Collis is a related party transaction, as it involves an insider acquiring company securities.

Stakeholder Impact

• Shareholders: This transaction is likely to be viewed positively by existing and potential shareholders, as it signals insider confidence and aligns management's interests with theirs.
• Employees: While not directly impacted, a positive market sentiment could indirectly boost employee morale.

Key Dates

Recommendation

The significant purchase of common stock by a director, Steven H. Collis, for over $869,000, signals strong insider confidence in Elevance Health's future prospects and current valuation. This type of insider buying is often interpreted by seasoned investors as a bullish indicator, suggesting that those with the most intimate knowledge of the company believe the stock is undervalued or poised for growth. While not a guarantee, it provides a compelling reason to consider a "buy" recommendation, especially for long-term investors.

Keywords

Elevance Health, ELV, Insider Buy, Director Purchase, Stock Acquisition, Form 4, Healthcare Stock, Steven H. Collis, Rule 10b5-1